8-K

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549



                                    FORM 8-K


                Current Report Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934



       Date of Report (Date of earliest event reported): November 14, 2007


                        Blonder Tongue Laboratories, Inc.
             (Exact Name of registrant as specified in its charter)



          Delaware                   1-14120                  52-1611421
(State or other jurisdiction (Commission File Number)    (I.R.S. Employer
      of incorporation)                                  Identification No.)


                One Jake Brown Road, Old Bridge, New Jersey 08857
               (Address of principal executive offices) (Zip Code)



       Registrant's telephone number, including area code: (732) 679-4000


                                 Not Applicable
          (Former name or former address, if changed since last report)


Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:


[_]  Written  communications  pursuant to Rule 425 under the  Securities Act (17
     CFR 230.425)


[_]  Soliciting  material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
     240.14a-12)


[_]  Pre-commencement   communications  pursuant  to  Rule  14d-2(b)  under  the
     Exchange Act (17 CFR 240.14d-2(b))


[_]  Pre-commencement   communications  pursuant  to  Rule  13e-4(c)  under  the
     Exchange Act (17 CFR 240.13e-4(c))







Item 2.02.  Results of Operations and Financial Condition

On November 14, 2007, Blonder Tongue  Laboratories,  Inc. issued a press release
announcing its unaudited financial results for the third quarter ended September
30, 2007. A copy of the press release is attached to this Report as Exhibit 99.1
and is  incorporated  herein by  reference.  The  information  disclosed in this
report,  including  Exhibit 99.1  hereto,  is being  furnished  and shall not be
deemed  "filed" for  purposes of Section 18 of the  Securities  Exchange  Act of
1934.

Item 9.01.  Financial Statements and Exhibits

(a)      Not applicable


(b)      Not applicable


(c)      Not applicable


(d)      The following exhibits are filed herewith:


     Exhibit 99.1 Press Release dated November 14, 2007.








                                    SIGNATURE


     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                    BLONDER TONGUE LABORATORIES, INC.



                                    By:/s/ Eric Skolnik
                                         Eric Skolnik
                                         Senior Vice President and
                                         Chief Financial Officer

Date: November 14, 2007







                                       2






                                  EXHIBIT INDEX


         Exhibit No.                                 Description

         Exhibit 99.1         Press Release of Blonder Tongue Laboratories, Inc.
                              dated November 14, 2007 regarding its unaudited
                              financial results for the third quarter ended
                              September 30, 2007.

EX-99

                                                                    EXHIBIT 99.1

[LOGO]


                                                             One Jake Brown Road
                                                                   P.O. Box 1000
                                               Old Bridge, New Jersey 08857-1000
                                           Tel: 732-679-4000   Fax: 732-679-4353






   FOR IMMEDIATE RELEASE             CONTACT:         James A. Luksch
                                                         Chairman and
                                                         Chief Executive Officer
                                                         (732) 679-4000

                BLONDER TONGUE REPORTS 2007 THIRD QUARTER RESULTS

OLD BRIDGE, NEW JERSEY,  November 14, 2007 - Blonder Tongue  Laboratories,  Inc.
(AMEX: "BDR") today announced its sales and earnings for the third quarter ended
September 30, 2007.

Net sales increased  $158,000,  or 1.7%, to $9,246,000 in the third three months
of 2007 from $9,088,000 in the third three months of 2006. The increase in sales
is  primarily  attributed  to an increase in digital  product  sales offset by a
decrease in fiber,  distribution and interdiction product sales. Digital product
sales were  $1,544,000  and  $958,000,  fiber  products  sales were $388,000 and
$647,000,   distribution  product  sales  were  $1,771,000  and  $1,977,000  and
interdiction  product sales were $151,000 and $319,000 in the third three months
of 2007 and 2006, respectively.

Cost of goods sold  increased to  $5,758,000  for the third three months of 2007
from  $5,650,000  for the  third  three  months  of  2006,  and  increased  as a
percentage  of sales to 62.3% from 62.2%.  The  increase  was  attributed  to an
unfavorable product mix.

Earnings from continuing operations after income taxes was $572,000 or $0.09 per
share for the third  three  months of 2007  compared  to a $345,000 or $0.04 per
share for the comparable period in 2006.

Commenting on the third quarter 2007 results,  James A. Luksch,  Chief Executive
Officer,  said,  "Our  China  initiative  remains on course and during the third
quarter we started to realize noticeable benefits from reduced costs due to this
effort. This is evidenced by the fact that our gross margin on sales of products
improved  from 36.3% in the second  quarter of 2007 (after  giving effect to our
increase  in  inventory  reserves)  to 37.7% in the third  quarter  of 2007.  We
anticipate  further  improvements  in gross margin in the fourth quarter of 2007
and continuing into 2008. Our third quarter sales were higher as compared to the
prior  year and we  continued  to show  improvement  sequentially  as our  third
quarter sales in 2007 were  approximately  14% higher than the second quarter of
2007."


Founded  in  1950,  Blonder  Tongue  Laboratories,   Inc.  has  evolved  from  a
manufacturer  of  electronic  equipment  for the  private  cable  industry  to a
principal  provider of integrated  network  solutions and technical  services to
broadband  service  providers  in  the  multiple  dwelling  unit,   lodging  and
hospitality, and institutional cable markets. The Company designs, manufactures,
and  supplies a  comprehensive  line of  equipment  to deliver  video  (analog &
digital),  high speed data and voice services over integrated  coaxial and fiber
optic broadband networks today and over packet based, Internet protocol networks
of the future.  For more information  regarding  Blonder Tongue or its products,
please  visit the  Company's  Web site at  www.blondertongue.com  or contact the
Company directly at (732) 679-4000.


"Safe Harbor"  Statement under the Private  Securities  Litigation Reform Act of
1995: The information set forth above includes "forward-looking"  statements and
accordingly,  the cautionary  statements  contained in Blonder  Tongue's  Annual
Report and Form 10-K for the year ended December 31, 2006 (See Item 1: Business,
Item 1A:  Risk  Factors  and Item 7:  Management's  Discussion  and  Analysis of
Financial  Condition  and Results of  Operations),  and other  filings  with the
Securities and Exchange  Commission are  incorporated  herein by reference.  The
words  "believe",  "expect",  "anticipate",  "should",  "project",  and  similar
expressions identify  forward-looking  statements.  Readers are cautioned not to
place  undue  reliance  on  these  forward-looking  statements,   which  reflect
management's  analysis only as of the date hereof.  Blonder Tongue undertakes no
obligation to publicly revise these forward-looking statements to reflect events
or  circumstances  that arise after the date  hereof.  Blonder  Tongue's  actual
results may differ from the anticipated results or other expectations  expressed
in Blonder  Tongue's  "forward-looking"  statements,  including the  anticipated
gross margin improvements due to the China initiative.

                                     -MORE-




                        Blonder Tongue Laboratories, Inc.
                    Consolidated Summary of Operating Results
                      (in thousands, except per-share data)
                                   (unaudited)


                                        Three months ended     Nine months ended
                                           September 30,          September 30,
                                    --------------------     -------------------
                                    --------- ----------     ---------- --------
                                      2007       2006           2007      2006

Net sales                            $9,246     $9,088        $24,836   $28,567
Gross profit                          3,488      3,438          8,362     9,748
Earnings (loss) from operations         694        515           (734)      979
Earnings (loss) from
  continuing operations                 572        345         (1,092)      330
Loss from discontinued operations         -       (170)           (59)     (367)
Net earnings (loss)                    $572       $175        $(1,151)     $(37)
Basic and diluted earnings
  (loss) per share from
  continuing operations               $0.09      $0.04         $(0.17)    $0.04
Basic and diluted loss per
  share from discontinued
  operations                             $-     $(0.02)         $(0.01)  $(0.04)
Basic and diluted net earnings
  (loss) per share                    $0.09      $0.02         $(0.18)      $ -
Basic and diluted weighted
average shares outstanding:           6,222      7,515          6,222     7,845


                       Consolidated Summary Balance Sheets
                                 (in thousands)


                                                September 30,    December 31,
                                                     2007            2006
                                                  (unaudited)

Current assets                                       $14,204       $14,942
Property, plant, and equipment, net                    4,313         4,537
Total assets                                          26,693        27,222
Current liabilities                                    5,540         5,431
Long-term liabilities                                  1,375         1,559
Stockholders' equity                                  19,778        20,232

Total liabilities and stockholders' equity           $26,693       $27,222

                                       ###